Brazil Molecular Diagnostics Market Size & Outlook
Brazil molecular diagnostics market, 2018-2030 (US$M)
Related Markets
Brazil molecular diagnostics market highlights
- The Brazil molecular diagnostics market generated a revenue of USD 554.0 million in 2023 and is expected to reach USD 412.2 million by 2030.
- The Brazil market is expected to grow at a CAGR of -4.1% from 2024 to 2030.
- In terms of segment, outpatient facilities was the largest revenue generating end use in 2023.
- Home Care is the most lucrative end use segment registering the fastest growth during the forecast period.
Molecular diagnostics market data book summary
| Market revenue in 2023 | USD 554.0 million |
| Market revenue in 2030 | USD 412.2 million |
| Growth rate | -4.1% (CAGR from 2023 to 2030) |
| Largest segment | Outpatient facilities |
| Fastest growing segment | Home Care |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hospitals, Outpatient Facilities, Home Care |
| Key market players worldwide | Becton Dickinson & Co, BioMerieux SA, Bio-Rad Laboratories Inc, Abbott Laboratories, Agilent Technologies Inc, Danaher Corp, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Roche Holding AG, Siemens Healthineers AG ADR, Sysmex Corp |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.1% of the global molecular diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil molecular diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 168.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Molecular Diagnostics Market Scope
Molecular Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil molecular diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 47.45% in 2023. Horizon Databook has segmented the Brazil molecular diagnostics market based on hospitals, outpatient facilities, home care covering the revenue growth of each sub-segment from 2018 to 2030.
Growth in financial and political stability has led to positive economic growth in Brazil. According to the International Agency for Research on Cancer, in 2020, around 594,908 new cancer cases were reported in Brazil. The growing incidence of cancer is expected to drive the demand for molecular testing.
In 2014, the Brazilian Public Health System included molecular diagnostic technologies for rare diseases in the list of reimbursed procedures. While the Public Health System included more genetic tests in its list of reimbursed procedures, inherited metabolic conditions are currently not reimbursed.
The inclusion of more tests in reimbursement criteria is expected to drive the country’s molecular diagnostics market. However, access to molecular testing in Brazil is currently limited to urban areas, due to the lack of infrastructure in rural settings. The increasing burden of infectious diseases is a major concern in Brazil.
Reasons to subscribe to Brazil molecular diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil molecular diagnostics market databook
-
Our clientele includes a mix of molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil molecular diagnostics market size, by end use, 2018-2030 (US$M)
Brazil Molecular Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
